Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 274

1.

HLA DRB1, DQA1 and DQB1 in Juvenile Onset Systemic Sclerosis.

Stevens AM, Kanaan SB, Torok KS, Medsger TA, Mayes MD, Reveille JD, Klein-Gitelman M, Reed AM, Lee T, Li SC, Henstorf G, Luu C, Aydelotte T, Nelson JL.

Arthritis Rheumatol. 2016 May 23. doi: 10.1002/art.39765. [Epub ahead of print]

PMID:
27214100
2.

Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis.

Domsic RT, Nihtyanova SI, Wisniewski SR, Fine MJ, Lucas M, Kwoh CK, Denton CP, Medsger TA Jr.

Arthritis Rheumatol. 2016 Apr;68(4):993-1003. doi: 10.1002/art.39490.

PMID:
26554637
3.

Progress in the evolution of systemic sclerosis classification criteria and recommendation for additional comparative specificity studies.

Masi AT, Medsger TA Jr.

J Rheumatol. 2015 Jan;42(1):8-10. doi: 10.3899/jrheum.141020. No abstract available.

PMID:
25554803
4.

Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.

Domsic RT, Dezfulian C, Shoushtari A, Ivanco D, Kenny E, Kwoh CK, Medsger TA Jr, Champion HC.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-154-60. Epub 2014 Nov 5.

5.

Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.

Johnson SR, Naden RP, Fransen J, van den Hoogen F, Pope JE, Baron M, Tyndall A, Matucci-Cerinic M, Denton CP, Distler O, Gabrielli A, van Laar JM, Mayes M, Steen V, Seibold JR, Clements P, Medsger TA Jr, Carreira PE, Riemekasten G, Chung L, Fessler BJ, Merkel PA, Silver R, Varga J, Allanore Y, Mueller-Ladner U, Vonk MC, Walker UA, Cappelli S, Khanna D.

J Clin Epidemiol. 2014 Jun;67(6):706-14. doi: 10.1016/j.jclinepi.2013.12.009. Epub 2014 Apr 8.

6.

Localized scleroderma and regional inflammatory myopathy.

Zivković SA, Freiberg W, Lacomis D, Domsic RT, Medsger TA.

Neuromuscul Disord. 2014 May;24(5):425-30. doi: 10.1016/j.nmd.2014.01.012. Epub 2014 Feb 1.

PMID:
24569141
7.

Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis.

Domsic RT, Nihtyanova SI, Wisniewski SR, Fine MJ, Lucas M, Kwoh CK, Denton CP, Medsger TA Jr.

Arthritis Rheumatol. 2014 Jun;66(6):1616-24. doi: 10.1002/art.38381.

8.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE.

Arthritis Rheum. 2013 Nov;65(11):2737-47. doi: 10.1002/art.38098. Epub 2013 Oct 3.

9.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE.

Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424.

PMID:
24092682
10.

Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.

Kaji K, Fertig N, Medsger TA Jr, Satoh T, Hoshino K, Hamaguchi Y, Hasegawa M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fujimoto M, Kuwana M.

Arthritis Care Res (Hoboken). 2014 Apr;66(4):575-84. doi: 10.1002/acr.22163.

11.

Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.

Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, Gomberg-Maitland M, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA Jr, Molitor JA, Preston IR, Schiopu E, Shapiro L, Silver R, Simms R, Varga J, Gordon JK, Steen VD.

Arthritis Care Res (Hoboken). 2014 Mar;66(3):489-95. doi: 10.1002/acr.22121.

12.

Significance of palpable tendon friction rubs in early diffuse cutaneous systemic sclerosis.

Doré A, Lucas M, Ivanco D, Medsger TA Jr, Domsic RT.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1385-9. doi: 10.1002/acr.21964.

13.

Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis.

Aida-Yasuoka K, Peoples C, Yasuoka H, Hershberger P, Thiel K, Cauley JA, Medsger TA Jr, Feghali-Bostwick CA.

Arthritis Res Ther. 2013 Jan 10;15(1):R10. doi: 10.1186/ar4140.

14.

Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA Jr.

Arthritis Rheum. 2013 Jan;65(1):236-46. doi: 10.1002/art.37706.

15.

A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis.

Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr.

Arthritis Rheum. 2012 Sep;64(9):2986-94. doi: 10.1002/art.34482.

16.

Anti-PM-Scl antibody in patients with systemic sclerosis.

Koschik RW 2nd, Fertig N, Lucas MR, Domsic RT, Medsger TA Jr.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S12-6. Epub 2012 May 29.

PMID:
22261302
17.

Commentary on myofascial release therapy in systemic lupus erythematosus and scleroderma.

Masi AT, Medsger TA Jr, Betts SJ.

J Bodyw Mov Ther. 2012 Jan;16(1):2-4; author reply 4-6. doi: 10.1016/j.jbmt.2011.09.001. Epub 2011 Oct 2. No abstract available.

PMID:
22196419
18.

Validation of potential classification criteria for systemic sclerosis.

Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA Jr, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):358-67. doi: 10.1002/acr.20684.

19.

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, Czirják L, Denton CP, Distler O, Furst DE, Gabrielli A, Herrick A, Inanc M, Kahaleh B, Kowal-Bielecka O, Medsger TA Jr, Mueller-Ladner U, Riemekasten G, Sierakowski S, Valentini G, Veale D, Vonk MC, Walker U, Chung L, Clements PJ, Collier DH, Csuka ME, Jimenez S, Merkel PA, Seibold JR, Silver R, Steen V, Tyndall A, Matucci-Cerinic M, Pope JE, Khanna D.

Arthritis Care Res (Hoboken). 2012 Mar;64(3):351-7. doi: 10.1002/acr.20679.

20.

Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed.

Domsic RT, Medsger TA Jr.

Nat Rev Rheumatol. 2011 Oct 4;7(11):628-30. doi: 10.1038/nrrheum.2011.152. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk